Effects of glucan treatment on the Th1/Th2 balance in patients with allergic rhinitis: A double-blind placebo-controlled study

European Cytokine Network

Volumn 16, Issue 2, 2005, Pages 128-134

  Kirmaz, Cengiz ^a,b   Bayrak, Papatya ^a   Yilmaz, Ozge ^a   Yuksel, Hasan ^a  

^a CELAL BAYAR UNIVERSITY MEDICAL FACULTY   (Turkey)

^b Department of Paediatric Allergy ^*  (Turkey)

Author keywords

Allergic rhinitis; Cytokine; Eosinophil; Glucan; Nasal lavage

Indexed keywords

CYTOKINE; GAMMA INTERFERON; GLUCAN; IMUNEKS; INTERLEUKIN 12; INTERLEUKIN 13; INTERLEUKIN 4; INTERLEUKIN 5; UNCLASSIFIED DRUG; PLACEBO;

ADULT; ALLERGIC RHINITIS; ALLERGY; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; EOSINOPHIL COUNT; FEMALE; HUMAN; IMMUNE RESPONSE; INFLAMMATION; MALE; NOSE MUCUS; OLIVE TREE; RANDOMIZED CONTROLLED TRIAL; TH1 CELL; TH2 CELL; TREATMENT OUTCOME; IMMUNOLOGY; PERENNIAL RHINITIS;

OLEA EUROPAEA;

DOUBLE-BLIND METHOD; GLUCANS; HUMANS; PLACEBOS; RHINITIS, ALLERGIC, PERENNIAL; TH1 CELLS; TH2 CELLS;

EID: 32944470688     PISSN: 11485493     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. Bousquet J, Van Cauwenberge P, Khaltaev N. Allergic rhinitis and its impact on asthma. J Allergy Clin Immunol 2001; 108(Suppl 5): 147.
2. Abbas AK, Murphy KM, Sher A. Functional diversity of helper T lymphocytes. Nat 1996; 383: 787.
3. Murphy KM, Reiner SL. The lineage decisions of helper T cells. Nat Rev Immunol 2002; 2: 933.
4. Romagnani S. Human Th1 and Th2 subsets: regulation of differentiation and role in protection and immunopathology. Int Arch Allergy Immunol 1992; 98: 279.
5. Wills-Karp M, Chiaramonte M. Interleukin-13 in asthma. Curr Opin Pulm Med 2003; 9: 21.
6. Romagnani S, Maggi E, Parronchi P, Macchia D, Piccinni MP, Ricci M. Increased number of Th2-like CD4 T cells in target organs and in the allergen-specific repertoire of allergic patients. Possible role of IL-4 production by non-T cells. Int Arch Allergy Appl Immunol 1991; 94: 133.
7. Huang SK, Xiao HQ, Kleine-Tebbe J, et al. IL-13 expression at the sites of allergen challenge in patients with asthma. J Immunol 1995; 155: 2688.
8. Belardelli F. Role of interferons and other cytokines in the regulation of the immune response. APMIS 1995; 103: 161.
9. Ghaffar A, Cullet RT, Woodruff MFA. Further analysis of the anti-tumor effect in vitro of peritoneal exudate cells from mice treated with Corynebacterium parvum. Br J Cancer 1975; 31: 15.
10. Mohr SJ, Chirigos MA, Fuhrman FS, Pryor JW. Pyran copolymer as an effective adjuvant to chemotherapy against a murine leukemia and solid tumor. Cancer Res 1975; 35: 3750.
11. Morahan PS, Kaplan AM. Macrophage activation and anti-tumor activity of biologic and synthetic agents. Intern J Cancer 1976; 17: 82.
12. Pillemer L, Ecker EE. Anticomplementary factor in fresh yeast. J Biol Chem 1941; 137: 139.
13. Di Carlo FJ, Fiore JV. On the composition of zymosan. Sci 1958; 127: 756.
14. Riggi SJ, Di Luzio NR. Identification of a reticuloendothelial stimulatory agent in zymosan. Am J Physiol 1961; 200: 297.
15. Wooles WR, Di Luzio NR. Reticuloendothelial function and the immune response. Science 1963; 142: 1078.
16. Stewart CC, Valeriote FA, Perez A. Preliminary observations on the effect of Glucan in combination with radiation and chemotherapy in four murine tumors. Cancer Treat Rep 1978; 62: 1867.
17. Luzio NR, Williams DL, McNamee RB, Malshet VG. Comparative evaluation of the tumor inhibitory and antibacterial activity of solubilized and particulate Glucan. Recent Results Cancer Res 1980; 75: 165.
18. Kasai S, Fujimoto S, Nitta K, Baba H, Kunimoto T. Antitumor activity of polymorphonuclear leukocytes activated by a β-1,3-D-Glucan. J Phamacobio-Dyn 1991; 14: 519.
19. Yoshino S, Tabata T, Hazama S, et al. Immunoregulatory effects of the antitumor polysaccharide lentinan on Th1/Th2 balance in patients with digestive cancers. Anticancer Res 2000; 20: 4707.
20. EAACI-guideline, Dreborg S, Frew A. EAACI Subcommittee on Skin Tests. Position paper. Allergen standardization and skin tests. Allergy 1993; 48(suppl. 14): 49.
21. Hellgren J, Jarlstedt J, Dimberg L, Toren K, Karlsson G. A study of some current methods for assessment of nasal histamine reactivity. Clin Otolaryngol 1997; 22: 536.
22. Hagemann H, Bauer PC, Costabel U. Comparability of various measurement methods in nasal provocation with allergens. Pneumol 2002; 56: 363.
23. Sim TC, Grant A, Hilsmeir KA, Fukuda Y, Alam R. Proinflammatory cytokines in nasal secretions of allergic subjects after antigen challenge. Am J Respir Crit Care Med 1994; 149: 339.
24. Pedersen B, Dahal R, Richards DH, Jacques LA, Larsen BB, Pichler W, et al. Once daily fluticasone propionate aqueous nasal spray controls symptoms of most patients with seasonal allergic rhinitis. Allergy 1995; 50: 794.
25. Benson M, Strannegard IL, Wennergren G, Strannegard O. Low levels of interferon-gamma in nasal fluid accompany raised levels of T-helper 2 cytokines in children with ongoing allergic rhinitis. Pediatr Allergy Immunol 2000; 11: 20.
26. Benson M, Strannegard IL, Wennergren G, Strannegard O. Cytokines in nasal fluids from school children with seasonal allergic rhinitis. Pediatr Allergy Immunol 1997; 8: 143.
27. Rapp J, Kosa L, Halasz A, Kereki E, Borzsonyi L. Levels of interleukin-4, interleukin-5, tryptase and eosinophil cationic protein of nasal lavage fluid in pollen allergic rhinitis. Orv Hetil 2000; 141: 1919.
28. Moverare R, Elfman L, Stalenheim G, Bjornsson E. Study of the Th1/Th2 balance, including IL-10 production, in cultures of peripheral blood mononuclear cells from birch-pollen-allergic patients. Allergy 2000; 55: 171.
29. Moverare R, Rak S, Elfman L. Allergen-specific increase in interleukin-(IL)-4 and IL-5 secretion from peripheral blood mononuclear cells during birch-pollen immunotherapy. Allergy 1998; 53: 275.
30. Durham SR. New insights into the mechanisms of immunotherapy. Eur Arch Otorhinolaryngol 1995; 252(Suppl 1): 64.
31. Murata Y, Shimamura T, Tagami T, Takatsuki F, Hamuro J. The skewing to Th 1 induced by lentinan is directed through the distinctive cytokine production by macrophages with elevated intracellular glutathione content. Int Immunopharmacol 2002; 2: 673.
32. Saito K, Yajima T, Nishimura H, Aiba K, Ishimitsu R, Matsuguchi T, et al. Soluble branched beta-(1,4)glucans from Acetobacter species show strong activities to induce interleukin-12 in vitro and inhibit T-helper 2 cellular response with immunoglobulin E production in vivo. J Biol Chem 2003; 278: 38571.
33. Oda N, Yamashita N, Minoguchi K, Takeno M, Kaneko S, Sakane T, et al. Long-term analysis of allergen-specific T cell clones from patients with asthma treated with allergen rush immunotherapy. Cell Immunol 1998; 190: 43.